| Product Information |
|
| Registration Number |
DR-XY46926
|
| Generic Name |
Irinotecan Hydrochloride Trihydrate
|
| Brand Name |
Irinovid
|
| Dosage Strength |
20mg/Ml (40mg/2mL and 100mg/5mL)
|
| Dosage Form |
Concentrate Solution for I.V. Infusion
|
| Classification |
Prescription Drug (RX)
|
| Pharmacologic Category |
-
|
| Packaging |
2mL (net content) in 2mL-capacity amber glass vial sealed with 13mm butyl coated rubber stopper and sealed with aluminum-plastic cap (Box of 1's) 5mL (net content) in 6mL-capacity amber glass vial sealed with 20mm butyl coated rubber stopper and aluminum-plastic cap (Box of 1's)
|
| Manufacturer |
Qilu Pharmaceutical (Hainan) Co., Ltd.
|
| Country of Origin |
China
|
| Trader |
|
| Importer |
Hovid, Inc.
|
| Distributor |
Hovid, Inc.
|
| Application Type |
-
|
| Issuance Date |
29 June 2020
|
| Expiry Date |
29 June 2025
|